TransMedics Group, Inc.
TMDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $5 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $4 | $5 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -8.6% | 9.6% | 18% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 58.8% | 61.4% | 61.5% | 59.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 23.2% | 29.5% | 25.3% | 13.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 16.9% | 22.2% | 17.9% | 5.6% |
| EPS Diluted | 0.66 | 0.92 | 0.7 | 0.19 |
| % Growth | -28.3% | 31.4% | 268.4% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |